| Literature DB >> 22236653 |
Catherine Uyttenhove1, Jacques Van Snick.
Abstract
Braking B cell tolerance to generate antibodies against autologous cytokines or chemokines offers an alternative to gene inactivation for functional analysis of these factors in vivo. It is clearly less potent than the genetic approach but offers the advantage of extreme flexibility. The basic principle is to enable a self-reactive B cell to attract T cell help by presenting foreign peptides, a process we called "deceptive" antigen presentation. We here review the different auto-vaccine procedures that are currently used and provide several examples of functional information acquired by this procedure or by mAbs derived from auto-vaccinated mice. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22236653 DOI: 10.1016/j.cytogfr.2011.12.001
Source DB: PubMed Journal: Cytokine Growth Factor Rev ISSN: 1359-6101 Impact factor: 7.638